Two different dose-intensification regimens with ustekinumab in patients with Crohn’s experiencing loss of effect of this drug leads to similar chance of recapturing control of the disease.
Gastroenterology (AGA) published a clinical update in Research Highlights on 24 Feb 2026.
The item focuses on The Effect of Dose Intensification After Secondary Loss of Response to Ustekinumab in Crohn’s Disease: Results of the REScUE Study.
Review the original article for the full source wording and details.